The AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN -0.16% slumped 0.51% to $58.10 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +2.68% falling 2.51% to 14,806.81 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.61% falling 0.49% to 36,113.62. The ADR's fall snapped a four-day winning streak. AstraZeneca PLC ADR closed $6.11 below its 52-week high ($64.21), which the company achieved on November 2nd.
The ADR demonstrated a mixed performance when compared to some of its competitors Thursday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV -0.91% fell 1.74% to $133.52, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +0.02% fell 0.39% to $230.85, and Gilead Sciences Inc. /zigman2/quotes/210293917/composite GILD -0.83% fell 0.51% to $71.88. Trading volume (3.5 M) remained 1.3 million below its 50-day average volume of 4.8 M.